Aileron Therapeutics to Present at the H.C. Wainwright 21st Annual Global Investment Conference in New York
Aileron Therapeutics, Inc. (ALRN)
Last aileron therapeutics, inc. earnings: 11/7 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.aileronrx.com
Company Research
Source: GlobeNewswire
WATERTOWN, Mass., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Aileron Therapeutics (NASDAQ: ALRN), the clinical-stage leader in the field of stabilized cell-permeating peptides to treat cancer and other diseases, today announced that Manuel Aivado, MD, PhD, President & Chief Executive Officer, will present a corporate overview and host one-on-one investor meetings at the H.C. Wainwright 21st Annual Global Investment Conference, being held on September 8-10, 2019 at the Lotte New York Palace Hotel in New York, NY. Details on the presentation are as follows: Presentation Details:Event: H.C. Wainwright 21st Annual Global Investment ConferenceDate: Monday, September 9, 2019Time: 10:50 a.m. – 11:15 a.m. EDTLocation: Lotte New York Palace Hotel, Holmes I (4th Floor) Archived presentation materials will be available following the event on the Events & Presentations section of Aileron’s website (click here). About ALRN-6924ALRN-6924 is a first-in-class, stabilized cell-permeating alpha-helical
Show less
Read more
Impact Snapshot
Event Time:
ALRN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ALRN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ALRN alerts
High impacting Aileron Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
ALRN
News
- Aileron Therapeutics to Present at Two Upcoming Investor Conferences [Yahoo! Finance]Yahoo! Finance
- Aileron Therapeutics to Present at Two Upcoming Investor ConferencesGlobeNewswire
- Aileron Therapeutics Announces Closing of Underwritten Registered Direct Offering of up to Approximately $40 MillionGlobeNewswire
- Aileron Therapeutics Announces Pricing of Underwritten Registered Direct Offering Priced At-The-Market Under Nasdaq Rules of up to Approximately $40 Million [Yahoo! Finance]Yahoo! Finance
- Aileron Therapeutics Announces Pricing of Underwritten Registered Direct Offering Priced At-The-Market Under Nasdaq Rules of up to Approximately $40 MillionGlobeNewswire
ALRN
Analyst Actions
- 4/18/24 - Ladenburg Thalmann
ALRN
Sec Filings
- 5/1/24 - Form 4
- 5/1/24 - Form 8-K
- 5/1/24 - Form 424B5
- ALRN's page on the SEC website